Equities

IRIDEX Corp

IRIX:NAQ

IRIDEX Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.80
  • Today's Change0.08 / 4.65%
  • Shares traded26.72k
  • 1 Year change-10.00%
  • Beta0.7982
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year IRIDEX Corp's revenues fell -8.96% from 56.97m to 51.87m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 7.55m to a larger loss of 9.57m.
Gross margin38.82%
Net profit margin-22.79%
Operating margin-22.47%
Return on assets-33.90%
Return on equity-150.28%
Return on investment-56.74%
More ▼

Cash flow in USDView more

In 2023, cash reserves at IRIDEX Corp fell by 6.89m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 6.75m for operations while cash used for investing totalled 109.00k.
Cash flow per share-0.6398
Price/Cash flow per share--
Book value per share0.1577
Tangible book value per share0.016
More ▼

Balance sheet in USDView more

IRIDEX Corp has a Debt to Total Capital ratio of 51.25%.
Current ratio1.54
Quick ratio0.845
Total debt/total equity1.05
Total debt/total capital0.5125
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.